TuHURA Biosciences
HURA
10 hedge funds and large institutions have $464K invested in TuHURA Biosciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 15 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
24% more capital invested
Capital invested by funds: $375K → $464K (+$88.5K)
0.12% more ownership
Funds ownership: 0% → 0.12% (+0.12%)
58% less funds holding
Funds holding: 24 → 10 (-14)
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$53.3K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.2K |
| 3 |
Morgan Stanley
New York
|
+$26.7K |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
+$13.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$30K |
| 2 |
S
swisspartners
Vaduz,
Liechtenstein
|
-$30K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28.2K |
| 4 |
VF
Virtu Financial
New York
|
-$18K |
| 5 |
LPL Financial
San Diego,
California
|
-$5K |
HURA Hedge Fund Activity: Q4 2022 in Review
10 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2022, worth a combined $464K — up 24% from $375K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of HURA and 1 opened new positions — a net loss of 14 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was State Street, adding an estimated $53.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $30K sold.
- 10 institutional investors held TuHURA Biosciences (HURA) as of Q4 2022, down from 24 in Q3 2022.
- Funds reported $464K of TuHURA Biosciences stock for Q4 2022, up 24% quarter-over-quarter.
- 1 fund opened new TuHURA Biosciences positions in Q4 2022 and 15 closed out, a net change of -14 holders.
- The largest TuHURA Biosciences buyer in Q4 2022 was State Street, an estimated $53.3K added.
- The largest TuHURA Biosciences seller in Q4 2022 was Renaissance Technologies, an estimated $30K sold.
Based on aggregated 13F filings for Q4 2022.